This report contains important business data for the infectious disease immunoassay, market, a high-growth area of immunoassy IVD testing. The report contains: Global Lab-based Infectious Disease Immunoassay Market Sizing for the following infection types:
Other Infectious Disease
Kalorama Information's report, The World Market for Infectious Disease Immunoassays, provides important business planning data for companies in the immunoassay market, investing in the field, or considering expansion. The following are among the data provided in the report:
Global Lab-based Infectious Disease Immunoassay Sales 2016 [Hepatitis, HIV, STD, TORCH, Respiratory, HAIs, Other Infectious Disease (in millions$))
Global Lab-based Infectious Disease Immunoassay Market Share % 2016
Lab-Based Immunoassay Market by Geographic Region 2021
POC Infectious Disease Immunoassay Market
Lab-Based Immunoassay Infectious Disease Market by Country (US, Germany, France, UK, Italy, Spain, China, Brazil, Saudi Arabia, Turkey, Canada)
POC Infectious Disease Immunoassay Market by Country(US, Germany, France, UK, Italy, Spain, China, Brazil, Saudi Arabia, Turkey, Canada)
Trends and Information
Some infectious disease immunoassays are being replaced with molecular assays. For example, most chlamydia and gonorrhea testing in developed countries is performed with molecular diagnostic assays rather than with immunoassays. A major driving factor in this conversion to molecular testing for chlamydia and gonorrhea was the increased sensitivity of these molecular tests compared to traditional immunoassays, and especially compared to traditional rapid tests such as lateral flow-based assays. However, many improvements have been made with immunoassays to improve the technical performance of these assays, including better sensitivity. Innovations in immunoassay technology and platforms have been discussed in Chapter 4, and many companies developing these new, innovative platforms are profiled in this report.
A key area of immunoassay testing is in detecting infectious diseases. The infectious disease immunoassay market is large because of the many different infectious agents affecting the population. Common infectious disease immunoassays performed in central laboratories are typically categorized into groups such as hepatitis, retroviral testing, sexually transmitted diseases, TORCH, and other infectious diseases. Infectious disease immunoassays are used in point-of-care setting or when rapid testing is needed. Immunoassays are also used to screen blood and blood products in order to prevent transfusion-transmitted infections.
Companies involved in the infectious disease immunoassay market include:
Accubiotech Co, Ltd.
Arlington Scientific, Inc.
Atlas Link Biotech Co., Ltd
Beckman Coulter, Inc
Becton Dickinson (Bd)
Bio-Rad Laboratories Inc
Bioscan Screening Systems, Inc.
Chembio Diagnostic Systems, Inc.
Diasource Immunoassays Sa
Erba Diagnostics, Inc.
Grifols International S.A.
Hema Diagnostic Systems, Llc
Labsystems Diagnostics Oy
Meridian Bioscience, Inc
Novatec Immunodiagnostica Gmbh
Oncimmune Holdings Plc.
Orasure Technologies, Inc.
Response Biomedical Corp
Savyon Diagnostics Ltd.
Standard Diagnostics, Inc.
Thermo Fisher Scientific, Inc
Trinity Biotech Plc
Search inside this report
Departmental Site License (one location, 10 users)